ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,223.98
-0.44%
Dow Jones
42,732.13
0.80%
Gold vs US Dollar
2,640.60
0.00%
Brent Oil
76.495
0.00%
Bitcoin
97,587.30
-0.63%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Vistagen Therapeutics Inc (VTGN) Share Price

VTGN Vistagen Therapeutics Inc

3.40
0.085 (2.56%)
04 Jan 2025 - Closed
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Vistagen Therapeutics Inc NASDAQ:VTGN NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.085 2.56 3.40 1.71 3.77 3.395 3.15 3.36 498,019 05:00:08   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 1.06M -29.36M -1.0545 -3.16 92.3M
 Type  Size  Price  Time  Units 
 9 1 3.37 00:15:08 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore VTGN News
06/12/202421:49EDGAR2Form 8-K - Current report
14/11/202421:53EDGAR2Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
14/11/202421:19EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
14/11/202413:30BWVistagen to Present at the Stifel 2024 Healthcare Conference
07/11/202421:34EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202421:20BWVistagen Reports Fiscal Year 2025 Second Quarter Financial Results and Corporate Update
05/11/202413:30BWVistagen to Present at the 2024 Neuroscience Education Institute Congress
Period
Draw mode
Data Downloads for VTGN

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Vistagen Therapeutics Inc Articles

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads